BioSpace News Archive

Business

Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients

Ainos, Inc. today announced that it has signed a Memorandum of Understanding with Merdury Biopharmaceutical Corp., a Taipei Exchange Emerging Stock Board listed company (TPEx: Code 6932) (“Merdury”), to jointly explore and develop a strategic business relationship.

March 14, 2023
·
5 min read
Drug Development

Servier’s Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)

Servier announced today that the Phase 3 INDIGO clinical trial investigating vorasidenib in monotherapy for patients with residual or recurrent IDH mutant low-grade glioma met its primary endpoint of progression free survival (PFS) and the key secondary endpoint of time to next intervention (TTNI).

March 14, 2023
·
8 min read
Business

Newron Announces 2022 Financial Results and Provides Outlook For 2023

Newron Pharmaceuticals S.p.A. today announced its financial results and operational highlights for the business year ended December 31, 2022, and provided an outlook for 2023.

March 14, 2023
·
15 min read
Biotech Bay

Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease

Alterity Therapeutics today announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office (USPTO) has now been granted.

March 14, 2023
·
6 min read
Biotech Bay

InsightRX Continues Accelerated Growth with Life Sciences Organizations and Health Systems

InsightRX – which provides cloud-based precision medicine software to optimize treatment decisions – capped off another successful year in 2022.

March 14, 2023
·
4 min read
Genetown

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum - March 14, 2023

Repligen Corporation today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 21-22.

March 14, 2023
·
2 min read
BioMidwest

Abeona Therapeutics Announces Update on AAV Ophthalmology Program

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced three internally developed investigational preclinical gene therapy product candidates from its ophthalmology program.

March 14, 2023
·
7 min read
Biotech Beach

Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies

Reneo Pharmaceuticals, Inc. today announced that the company has achieved the target enrollment in the pivotal STRIDE study of mavodelpar (REN001) in primary mitochondrial myopathies (PMM).

March 14, 2023
·
4 min read
Business

Biogen Appoints Chuck Triano as Head of Investor Relations

Biogen Inc. (NASDAQ: BIIB) today announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023.

March 14, 2023
·
5 min read
Business

Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives

Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today provided a corporate update and reported financial results for the fourth quarter and full year 2022.

March 14, 2023
·
12 min read